S&P 500 7,370.81 â–ŧ 101.98 (-1.36%) DOW 51,692.85 â–ŧ 19.86 (-0.04%) NASDAQ 25,611.30 â–ŧ 555.30 (-2.12%) US Markets Closed â€ĸ 05:35 PM ET

GBIO

Generation Bio Co.

Price Chart

No historical data available

Latest Quote

$5.34

+0.00 (+0.00%)
Current Price
Previous Close $5.34
Open $5.70
Day High $5.71
Day Low $5.34
Volume 551,924
Fetched: 2026-04-10T12:22:22
Stock Information
Shares Outstanding 6.74M
Total Debt $26.10M
Cash Equivalents $89.62M
Revenue $15.27M
Net Income $-62.63M
Sector Healthcare
Industry Biotechnology
Market Cap $35.98M
EPS (TTM) $-9.37
Exchange NMS
🌐 Visit Website
Recent Price History
No history data available. Data will be fetched automatically.
About Generation Bio Co.

Generation Bio Co., a biotechnology company, discovers, develops, and commercializes redosable therapeutics that reprogram T cells in vivo to reduce or eliminate the production and persistence of autoreactive T cells. It develops cell-targeted lipid nanoparticles (ctLNP) to selectively deliver small interfering RNA (siRNA) T cells to selectively delivery, intracellular, and genetically precise mechanism of target engagement could unlock a series of high-value historically undruggable disease-driving genes in autoimmunity. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Period:
Loading...
Income Statement (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
Total Revenue $19,892,000 $5,904,000 $0 $0
Operating Revenue $19,892,000 $5,904,000 $0 $0
Expenses
Total Expenses $99,085,000 $144,467,000 $141,182,000 $119,101,000
Other Income Expense $-63,197,000 - - -
Net Non Operating Interest Income Expense $10,722,000 $11,951,000 $4,543,000 $-50,000
Operating Expense $99,085,000 $144,467,000 $141,182,000 $119,101,000
General And Administrative Expense $37,780,000 $50,850,000 $44,464,000 $33,854,000
Interest Expense - - - $50,000
Total Other Finance Cost - - - $50,000
Interest Expense Non Operating - - - $50,000
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-131,668,000 $-126,612,000 $-136,639,000 $-119,151,000
Net Interest Income $10,722,000 $11,951,000 $4,543,000 $-50,000
Interest Income $10,722,000 $11,951,000 $4,543,000 -
Normalized Income $-68,471,000 $-126,612,000 $-136,639,000 $-119,151,000
Net Income From Continuing And Discontinued Operation $-131,668,000 $-126,612,000 $-136,639,000 $-119,151,000
Total Operating Income As Reported $-142,390,000 $-138,563,000 $-141,182,000 $-119,101,000
Net Income Common Stockholders $-131,668,000 $-126,612,000 $-136,639,000 $-119,151,000
Net Income $-131,668,000 $-126,612,000 $-136,639,000 $-119,151,000
Net Income Including Noncontrolling Interests $-131,668,000 $-126,612,000 $-136,639,000 $-119,151,000
Net Income Continuous Operations $-131,668,000 $-126,612,000 $-136,639,000 $-119,151,000
Pretax Income $-131,668,000 $-126,612,000 $-136,639,000 $-119,151,000
Special Income Charges $-63,197,000 $0 $0 -
Interest Income Non Operating $10,722,000 $11,951,000 $4,543,000 -
Operating Income $-79,193,000 $-138,563,000 $-141,182,000 $-119,101,000
Per Share
Diluted EPS $-19.80 $-19.60 $-23.50 $-21.20
Basic EPS $-19.80 $-19.60 $-23.50 $-21.20
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-11,065,000 $-133,300,000 $-136,052,000 $-114,569,000
Total Unusual Items $-63,197,000 $0 $0 -
Total Unusual Items Excluding Goodwill $-63,197,000 $0 $0 -
Reconciled Depreciation $4,931,000 $5,263,000 $5,130,000 $4,532,000
EBITDA (Bullshit earnings) $-74,262,000 $-133,300,000 $-136,052,000 $-114,569,000
EBIT $-79,193,000 $-138,563,000 $-141,182,000 $-119,101,000
Diluted Average Shares $6,662,424 $6,448,352 $5,811,489 $5,629,540
Basic Average Shares $6,662,424 $6,448,352 $5,811,489 $5,629,540
Diluted NI Availto Com Stockholders $-131,668,000 $-126,612,000 $-136,639,000 $-119,151,000
Other Special Charges $63,197,000 - - -
Research And Development $61,305,000 $93,617,000 $96,718,000 $85,247,000
Selling General And Administration $37,780,000 $50,850,000 $44,464,000 $33,854,000
Other Gand A $16,734,000 $20,498,000 $16,952,000 $11,704,000
Salaries And Wages $21,046,000 $30,352,000 $27,512,000 $22,150,000
Fetched: 2026-02-09
Balance Sheet (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Assets
Net Tangible Assets $86,204,000 $203,128,000 $282,493,000 $381,746,000
Total Assets $231,197,000 $374,758,000 $376,264,000 $476,771,000
Total Non Current Assets $38,294,000 $102,140,000 $89,248,000 $97,585,000
Other Non Current Assets $2,591,000 $6,389,000 $7,391,000 $6,095,000
Non Current Prepaid Assets $100,000 $100,000 - -
Current Assets $192,903,000 $272,618,000 $287,016,000 $379,186,000
Other Current Assets $2,421,000 $290,000 $259,000 $4,041,000
Assets Held For Sale Current $163,000 $0 - -
Prepaid Assets $3,537,000 $3,816,000 $7,006,000 $4,041,000
Receivables $1,559,000 $4,148,000 $660,000 $0
Other Receivables $1,224,000 $3,960,000 $395,000 -
Accrued Interest Receivable $335,000 $188,000 $265,000 -
Cash Cash Equivalents And Short Term Investments $185,223,000 $264,364,000 $279,091,000 $375,145,000
Cash And Cash Equivalents $76,301,000 $66,446,000 $93,171,000 $375,145,000
Non Current Deferred Assets - $433,000 $434,000 $461,000
Accounts Receivable - - $395,000 $0
Debt
Total Debt $93,560,000 $97,894,000 $81,707,000 $80,825,000
Long Term Debt And Capital Lease Obligation $80,554,000 $89,774,000 $74,621,000 $76,217,000
Current Debt And Capital Lease Obligation $13,006,000 $8,120,000 $7,086,000 $4,608,000
Liabilities
Total Liabilities Net Minority Interest $144,993,000 $171,630,000 $93,771,000 $95,025,000
Total Non Current Liabilities Net Minority Interest $109,938,000 $131,716,000 $74,621,000 $76,217,000
Other Non Current Liabilities $223,000 - - -
Non Current Deferred Liabilities $29,161,000 $41,942,000 $0 $0
Current Liabilities $35,055,000 $39,914,000 $19,150,000 $18,808,000
Other Current Liabilities $2,658,000 $406,000 $426,000 $676,000
Current Deferred Liabilities $10,582,000 $12,919,000 $0 $0
Payables And Accrued Expenses $2,834,000 $5,261,000 $3,668,000 $5,945,000
Payables $1,408,000 $2,346,000 $662,000 $2,023,000
Accounts Payable $1,408,000 $2,346,000 $662,000 $2,023,000
Equity
Common Stock Equity $86,204,000 $203,128,000 $282,493,000 $381,746,000
Total Equity Gross Minority Interest $86,204,000 $203,128,000 $282,493,000 $381,746,000
Stockholders Equity $86,204,000 $203,128,000 $282,493,000 $381,746,000
Gains Losses Not Affecting Retained Earnings $159,000 $274,000 $-83,000 $0
Other Equity Adjustments $159,000 $274,000 $-83,000 -
Retained Earnings $-703,045,000 $-571,377,000 $-444,765,000 $-308,126,000
Other
Ordinary Shares Number $6,697,197 $6,620,555 $5,950,543 $5,696,961
Share Issued $6,697,197 $6,620,555 $5,950,543 $5,698,069
Tangible Book Value $86,204,000 $203,128,000 $282,493,000 $381,746,000
Invested Capital $86,204,000 $203,128,000 $282,493,000 $381,746,000
Working Capital $157,848,000 $232,704,000 $267,866,000 $360,378,000
Capital Lease Obligations $93,560,000 $97,894,000 $81,707,000 $80,825,000
Total Capitalization $86,204,000 $203,128,000 $282,493,000 $381,746,000
Additional Paid In Capital $789,083,000 $774,224,000 $727,335,000 $689,866,000
Capital Stock $7,000 $7,000 $6,000 $6,000
Common Stock $7,000 $7,000 $6,000 $6,000
Preferred Stock $0 $0 $0 $0
Non Current Deferred Revenue $29,161,000 $41,942,000 $0 $0
Long Term Capital Lease Obligation $80,554,000 $89,774,000 $74,621,000 $76,217,000
Current Deferred Revenue $10,582,000 $12,919,000 $0 -
Current Capital Lease Obligation $13,006,000 $8,120,000 $7,086,000 $4,608,000
Pensionand Other Post Retirement Benefit Plans Current $5,975,000 $13,208,000 $7,970,000 $7,579,000
Current Accrued Expenses $1,426,000 $2,915,000 $3,006,000 $3,922,000
Net PPE $35,603,000 $95,651,000 $81,423,000 $91,029,000
Accumulated Depreciation $-22,911,000 $-19,695,000 $-14,538,000 $-10,016,000
Gross PPE $58,514,000 $115,346,000 $95,961,000 $101,045,000
Leases $20,909,000 $20,865,000 $20,786,000 $17,374,000
Construction In Progress $192,000 $7,030,000 $13,000 $3,748,000
Other Properties $34,660,000 $84,711,000 $72,827,000 $77,969,000
Machinery Furniture Equipment $2,753,000 $2,740,000 $2,335,000 $1,954,000
Properties $0 $0 $0 $0
Other Short Term Investments $108,922,000 $197,918,000 $185,920,000 $0
Treasury Shares Number - - - $1,108
Fetched: 2026-02-09
Cash Flow Statement (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Free Cash Flow
Free Cash Flow $-90,964,000 $-60,142,000 $-111,249,000 $-97,779,000
Operating Activities
Operating Cash Flow $-88,563,000 $-52,745,000 $-102,448,000 $-91,821,000
Cash Flow From Continuing Operating Activities $-88,563,000 $-52,745,000 $-102,448,000 $-91,821,000
Operating Gains Losses - $27,000 $41,000 $237,000
Investing Activities
Capital Expenditure $-2,401,000 $-7,397,000 $-8,801,000 $-5,958,000
Investing Cash Flow $94,529,000 $-9,698,000 $-192,515,000 $193,047,000
Cash Flow From Continuing Investing Activities $94,529,000 $-9,698,000 $-192,515,000 $193,047,000
Financing Activities
Issuance Of Capital Stock $0 $36,000,000 $0 $211,876,000
Financing Cash Flow $250,000 $35,817,000 $12,989,000 $214,671,000
Cash Flow From Continuing Financing Activities $250,000 $35,817,000 $629,000 $214,671,000
Net Other Financing Charges $-186,000 $-729,000 $11,729,000 $-955,000
Net Common Stock Issuance $0 $36,000,000 $0 $211,876,000
Common Stock Issuance $0 $36,000,000 $0 $211,876,000
Net Preferred Stock Issuance - - $0 $0
Preferred Stock Issuance - - $0 $0
Other
End Cash Position $78,453,000 $72,237,000 $98,863,000 $380,837,000
Beginning Cash Position $72,237,000 $98,863,000 $380,837,000 $64,940,000
Changes In Cash $6,216,000 $-26,626,000 $-281,974,000 $315,897,000
Proceeds From Stock Option Exercised $436,000 $546,000 $1,260,000 $3,750,000
Net Investment Purchase And Sale $96,734,000 $-2,301,000 $-183,714,000 $198,900,000
Sale Of Investment $232,000,000 $403,000,000 $140,000,000 $198,900,000
Purchase Of Investment $-135,266,000 $-405,301,000 $-323,714,000 $0
Net PPE Purchase And Sale $-2,205,000 $-7,397,000 $-8,801,000 $-5,853,000
Sale Of PPE $196,000 $0 $0 $105,000
Purchase Of PPE $-2,401,000 $-7,397,000 $-8,801,000 $-5,958,000
Change In Working Capital $-31,429,000 $53,537,000 $1,046,000 $4,175,000
Change In Other Working Capital $-15,118,000 $41,596,000 - -
Change In Other Current Liabilities $-8,615,000 $16,187,000 $881,000 $-3,701,000
Change In Other Current Assets $3,437,000 $-9,211,000 $4,640,000 $2,920,000
Change In Payables And Accrued Expense $-8,344,000 $5,374,000 $-591,000 $3,589,000
Change In Accrued Expense $-7,958,000 $4,287,000 $795,000 $1,833,000
Change In Payable $-386,000 $1,087,000 $-1,386,000 $1,756,000
Change In Account Payable $-386,000 $1,087,000 $-1,386,000 $1,756,000
Change In Prepaid Assets $-1,565,000 $3,156,000 $-3,489,000 $1,367,000
Change In Receivables $-1,224,000 $-3,565,000 $-395,000 $0
Other Non Cash Items $62,588,000 $27,000 $41,000 -
Stock Based Compensation $14,609,000 $24,341,000 $24,452,000 $17,857,000
Asset Impairment Charge $259,000 $39,000 $5,811,000 $0
Amortization Of Securities $-7,853,000 $-9,340,000 $-2,289,000 $529,000
Depreciation Amortization Depletion $4,931,000 $5,263,000 $5,130,000 $4,532,000
Depreciation And Amortization $4,931,000 $5,263,000 $5,130,000 $4,532,000
Net Income From Continuing Operations $-131,668,000 $-126,612,000 $-136,639,000 $-119,151,000
Gain Loss On Sale Of PPE - $27,000 $41,000 $237,000
Fetched: 2026-02-09